Gianluca Sala (G Sala)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Venues

University Chieti-Pescara

Università degli Studi Gabriele d'Annunzio Chieti e Pescara Scuola di Medicina e Scienze della Salute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Chieti-Pescara Feb 07 2020

Italy

Senior Lecturer :: Dipartmento di Scienze Mediche, Orali e Biotecnologiche

Università degli Studi Gabriele d'Annunzio Chieti e Pescara Scuola di Medicina e Scienze della Salute Aug 01 2015 - Feb 07 2020

Italy

Senior Scientist :: Scienze Mediche Orali e Biotecnologiche

Mediapharma s.r.l.

Italy

Senior Scientist

Università degli Studi Gabriele d'Annunzio Chieti e Pescara Scuola di Medicina e Scienze della Salute

Italy

Assegno di Ricerca

University College London

United Kingdom

Post-doctoral fellow :: Medicine

Gabriele d'Annunzio University of Chieti and Pescara Department of Architecture

Italy

Post-Graduate Fellow

Istituto Regina Elena

Italy

Post-graduate Fellow :: Immunology

Consorzio Mario Negri Sud

Italy

Graduate Fellow

Education History

Università degli Studi Gabriele d'Annunzio Chieti e Pescara Scuola di Medicina e Scienze della Salute

Italy

PHD

Publications

Beatrice Dufrusine, Emily Capone, Sara Ponziani, Rossano Lattanzio, Paola Lanuti, Francesco Giansanti, Vincenzo De Laurenzi, Stefano Iacobelli, Rodolfo Ippoliti, Annunziato Mangiola, Gianluca Trevisi, Gianluca Sala
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma. Molecular oncology (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Ilaria Cela, Vito Carlo Alberto Caponio, Emily Capone, Morena Pinti, Marco Mascitti, Lucrezia Togni, Lorenzo Lo Muzio, Corrado Rubini, Vincenzo De Laurenzi, Rossano Lattanzio, Vittoria Perrotti, Gianluca Sala
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma. Oral diseases (2023)
Emily Capone, Thordur Tryggvason, Ilaria Cela, Beatrice Dufrusine, Morena Pinti, Francesco Del Pizzo, Helga Sigrun Gunnarsdottir, Tommaso Grottola, Vincenzo De Laurenzi, Stefano Iacobelli, Rossano Lattanzio, Gianluca Sala
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target. Cell death discovery 9 (1) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Margot De Marco, Vanessa Gauttier, Sabrina Pengam, Caroline Mary, Bianca Ranieri, Anna Basile, Michela Festa, Antonia Falco, Francesca Reppucci, Anna Lisa Cammarota, Fausto Acernese, Vincenzo De Laurenzi, Gianluca Sala, Sergio Brongo, Masayuki Miyasaka, Shabnam Shalapour, Bernard Vanhove, Nicolas Poirier, Roberta Iaccarino, Michael Karin, Maria Caterina Turco, M Caterina Turco, Liberato Marzullo
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth. Cell death discovery 8 (1) (2022)
Jose M Vicencio, R Evans, R Green, Z An, J Deng, C Treacy, R Mustapha, J Monypenny, C Costoya, K Lawler, K Ng, K De-Souza, O Coban, Valentí Gómez, J Clancy, S H Chen, A Chalk, F Wong, P Gordon, C Savage, C Gomes, T Pan, G Alfano, L Dolcetti, J N E Chan, F Flores-Borja, P R Barber, G Weitsman, D Sosnowska, E Capone, S Iacobelli, D Hochhauser, J A Hartley, Maddy Parsons, J N Arnold, Simon M Ameer-Beg, Sergio A Quezada, Yosef Yarden, Gianluca Sala, Tony T Ng
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans. Cell death & disease 13 (3) (2022)
Claudia Rossi, Ilaria Cicalini, Maria Concetta Cufaro, Ada Consalvo, Prabin Upadhyaya, Gianluca Sala, Ivana Antonucci, Piero Del Boccio, Liborio Stuppia, Vincenzo De Laurenzi
Breast cancer in the era of integrating "Omics" approaches. Oncogenesis 11 (1) (2022)
Maria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, Andrea Costamagna, Edoardo Ratto, Federico Gulluni, Enza Di Gregorio, Erica Mina, Nicla Lorito, Marina Bacci, Rossano Lattanzio, Gianluca Sala, Paola Cappello, Francesco Novelli, Elisa Giovannetti, Caterina Vicentini, Silvia Andreani, Pietro Delfino, Vincenzo Corbo, Aldo Scarpa, Paolo Ettore Porporato, Andrea Morandi, Emilio Hirsch, Miriam Martini
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. Gut (2022)
Emily Capone, Rossano Lattanzio, Fabio Gasparri, Paolo Orsini, Cosmo Rossi, Valentina Iacobelli, Vincenzo De Laurenzi, Pier Giorgio Natali, Barbara Valsasina, Stefano Iacobelli, Gianluca Sala
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors. Pharmaceutics 13 (4) (2021)
Vittoria Perrotti, Vito Carlo Alberto Caponio, Marco Mascitti, Lorenzo Lo Muzio, Adriano Piattelli, Corrado Rubini, Emily Capone, Gianluca Sala
Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review. Cancers 13 (13) (2021)
Fabiana Alejandra Rossi, Juliana Haydeé Enriqué Steinberg, Ezequiel Hernán Calvo Roitberg, Molishree Umesh Joshi, Ahwan Pandey, Martín Carlos Abba, Beatrice Dufrusine, Simonetta Buglioni, Vincenzo De Laurenzi, Gianluca Sala, Rossano Lattanzio, Joaquín Maximiliano Espinosa, Mario Rossi
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer. Oncogenesis 10 (3) (2021)
Emily Capone, Stefano Iacobelli, Gianluca Sala
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target. Journal of translational medicine 19 (1) (2021)
Sandra Bibbo', Alessia Lamolinara, Emily Capone, Stefania Purgato, Alexia Tsakaneli, Valeria Panella, Michele Sallese, Cosmo Rossi, Paolo Ciufici, Valentina Nieddu, Vincenzo De Laurenzi, Manuela Iezzi, Giovanni Perini, Gianluca Sala, Arturo Sala
Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac. Oncogenesis 9 (1) (2020)
Emily Capone, Alessia Lamolinara, Fabio Pastorino, Roberta Gentile, Sara Ponziani, Giulia Di Vittorio, Daniela D'Agostino, Sandra Bibbò, Cosmo Rossi, Enza Piccolo, Valentina Iacobelli, Rossano Lattanzio, Valeria Panella, Michele Sallese, Vincenzo De Laurenzi, Francesco Giansanti, Arturo Sala, Manuela Iezzi, Mirco Ponzoni, Rodolfo Ippoliti, Stefano Iacobelli, Gianluca Sala
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers 12 (10) (2020)
Lucía Gandullo-Sánchez, Emily Capone, Alberto Ocaña, Stefano Iacobelli, Gianluca Sala, Atanasio Pandiella
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies. EMBO molecular medicine 12 (5) (2020)
Elisabetta Falvo, Alessandro Arcovito, Giamaica Conti, Giuseppe Cipolla, Martina Pitea, Veronica Morea, Verena Damiani, Gianluca Sala, Giulio Fracasso, Pierpaolo Ceci
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy. Pharmaceutics 12 (10) (2020)
Sara Ponziani, Giulia Di Vittorio, Giuseppina Pitari, Anna Maria Cimini, Matteo Ardini, Roberta Gentile, Stefano Iacobelli, Gianluca Sala, Emily Capone, David J Flavell, Rodolfo Ippoliti, Francesco Giansanti
Antibody-Drug Conjugates: The New Frontier of Chemotherapy. International journal of molecular sciences 21 (15) (2020)
Ilaria Casari, Alice Domenichini, Simona Sestito, Emily Capone, Gianluca Sala, Simona Rapposelli, Marco Falasca
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. Cancers 11 (11) (2019)
R Ferro, A Adamska, R Lattanzio, I Mavrommati, C E Edling, S A Arifin, C A Fyffe, Gianluca Sala, L Sacchetto, Giovanna Chiorino, V De Laurenzi, M Piantelli, Owen James Sansom, T Maffucci, M Falasca
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene 37 (49) (2018)

Gianluca Sala.css-eqlu8i{font-size:small;padding-left:4px;} (G Sala)

Publication Activity (10 Years)

Top Topics

Top Venues

Gianluca Sala (G Sala)